Devereux RB - Search Results

1

New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.

Bang CN, Gislason GH, Greve AM, Bang CA, Lilja A, Torp-Pedersen C, Andersen PK, Køber L, Devereux RB, Wachtell K. Bang CN, et al. Among authors: devereux rb. J Am Heart Assoc. 2014 Jan 21;3(1):e000382. doi: 10.1161/JAHA.113.000382. J Am Heart Assoc. 2014. PMID: 24449803 Free PMC article.

2

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Among authors: devereux rb. Hypertension. 2000 Jan;35(1 Pt 1):6-12. doi: 10.1161/01.hyp.35.1.6. Hypertension. 2000. PMID: 10642267

3

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Among authors: devereux rb. Am J Cardiol. 2000 Feb 15;85(4):466-72. doi: 10.1016/s0002-9149(99)00773-0. Am J Cardiol. 2000. PMID: 10728952 Clinical Trial.

4

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.

Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlöf B, Smith G, Roman MJ, Ibsen H, Aurigemma GP, Devereux RB. Wachtell K, et al. Among authors: devereux rb. Am J Cardiol. 2001 Jan 1;87(1):54-60. doi: 10.1016/s0002-9149(00)01272-8. Am J Cardiol. 2001. PMID: 11137834

5

Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.

Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlöf B, de Simone G, Devereux RB. Palmieri V, et al. Among authors: devereux rb. Am Heart J. 2001 May;141(5):784-91. doi: 10.1067/mhj.2001.114803. Am Heart J. 2001. PMID: 11320367 Clinical Trial.

6

Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.

Olsen MH, Wachtell K, Aalkjaer C, Devereux RB, Dige-Petersen H, Ibsen H. Olsen MH, et al. Among authors: devereux rb. Am J Hypertens. 2001 Sep;14(9 Pt 1):861-7. doi: 10.1016/s0895-7061(01)02148-3. Am J Hypertens. 2001. PMID: 11587150

7

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlöf B, Gerdts E, Wright JT Jr, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H, Devereux RB. Wachtell K, et al. Among authors: devereux rb. Am Heart J. 2002 Feb;143(2):319-26. doi: 10.1067/mhj.2002.119895. Am Heart J. 2002. PMID: 11835038 Clinical Trial.

8

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.

Wachtell K, Olsen MH, Dahlöf B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H. Wachtell K, et al. Among authors: devereux rb. J Hypertens. 2002 Mar;20(3):405-12. doi: 10.1097/00004872-200203000-00015. J Hypertens. 2002. PMID: 11875307

9

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Wachtell K, Bella JN, Rokkedal J, Palmieri V, Papademetriou V, Dahlöf B, Aalto T, Gerdts E, Devereux RB. Wachtell K, et al. Among authors: devereux rb. Circulation. 2002 Mar 5;105(9):1071-6. doi: 10.1161/hc0902.104599. Circulation. 2002. PMID: 11877357 Clinical Trial.

10

Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlöf B, Devereux RB; Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Gerdts E, et al. Among authors: devereux rb. Hypertension. 2002 Mar 1;39(3):739-43. doi: 10.1161/hy0302.105683. Hypertension. 2002. PMID: 11897755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

948 results

Search Page